American Journal of Ophthalmology
Volume 149, Issue 1 , Pages 10-17.e2 , January 2010

From the Laboratory to the Clinic: Molecular Genetic Testing in Pediatric Ophthalmology

  • Arlene V. Drack

      Affiliations

    • Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, Iowa
    • Corresponding Author InformationInquiries to Arlene V. Drack, Department of Ophthalmology and Visual Sciences, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52242
    • ,
  • Scott R. Lambert

      Affiliations

    • Department of Ophthalmology, Emory University, Atlanta, Georgia
    • ,
  • Edwin M. Stone

      Affiliations

    • Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, Iowa
    • Howard Hughes Medical Institute, Chevy Chase, Maryland

,Accepted 31 August 2009.

References 

  1. Yandell DW, Campbell TA, Dayton SH, et al. Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. N Engl J Med. 1989;321:1689–1695
  2. Berson EL, Rosner B, Sandberg MA, Dryja TP. Ocular findings in patients with autosomal dominant retinitis pigmentosa and a rhodopsin gene defect (Pro23His). Arch Ophthalmol. 1991;109:92–101
  3. Newman NJ, Biousse V. Hereditary optic neuropathies. Eye. 2004;18:1144–1160
  4. Kondo H, Qin M, Tahira T, Uchio E, Hayashi K. Severe form of familial exudative vitreoretinopathy caused by homozygous R417Q mutation in frizzled-4 gene. Ophthalmic Genet. 2007;28:220–223
  5. Robitaille JM, Wallace K, Zheng B, et al. Phenotypic overlap of familial exudative vitreoretinopathy (FEVR) with persistent fetal vasculature (PFV) caused by FZD4 mutations in two distinct pedigrees. Ophthalmic Genet. 2009;30:23–30
  6. Toomes C, Bottomley HM, Scott S, et al. Spectrum and frequency of FZD4 mutations in familial exudative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2004;45:2083–2090
  7. Genetests (GeneReviews). http://www.genetests.org/Accessed August 20, 2009
  8. Retinal Information Network. http://www.retnet.org/Accessed July 20, 2009
  9. Stone EM. Leber congenital amaurosis—a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture. Am J Ophthamol. 2007;144:791–811
  10. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med. 2008;358:2240–2248
  11. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med. 2008;358:2231–2239
  12. Hauswirth WW, Aleman TS, Kaushal S, et al. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of phase 1 trial. Human Gene Ther. 2008;19:979–990
  13. Mirzayans F, Gould DB, Heon E, et al. Axenfeld-Rieger syndrome resulting from mutation of the FKHL7 gene on chromosome 6p25. Eur J Hum Genet. 2000;8:71–74
  14. Saleem RA, Murphy TC, Liebmann JM, Walter MA. Identification and analysis of a novel mutation in the FOXC1 forkhead domain. Invest Ophthalmol Vis Sci. 2003;44:4608–4612
  15. Shields MB. Axenfeld-Rieger syndrome: a theory of mechanism and distinctions from the iridocorneal endothelial syndrome. Trans Am Ophthalmol Soc. 1983;81:736–784
  16. Eden U, Iggman D, Riise R, Tornqvist K. Epidemiology of aniridia in Sweden and Norway. Acta Ophthalmol. 2008;86:727–729
  17. Breslow NE, Norris R, Norkool PA, et al. Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2003;21:4579–4585
  18. Gronskov K, Olsen JH, Sand A, et al. Population-based risk estimates of Wilms tumor in sporadic aniridia (A comprehensive mutation screening procedure of PAX6 identifies 80% of mutations in aniridia). Hum Genet. 2001;109:11–18
  19. Crolla JA, Cawdery JE, Oley CA, et al. A FISH approach to defining the extent and possible clinical significance of deletions at the WAGR locus. J Med Genet. 1997;34:207–212
  20. Traboulsi EI, Koenekoop R, Stone EM. Lumpers or splitters? (The role of molecular diagnosis in Leber congenital amaurosis). Ophthalmic Genet. 2006;27:113–115
  21. Frank V, den Hollander AI, Bruchle NO, et al. Mutations of the CEP290 gene encoding a centrosomal protein cause Meckel-Gruber syndrome. Hum Mutat. 2008;29:45–52
  22. Chiang AP, Beck JS, Yen HJ, et al. Homozygosity mapping with SNP array identifies TRIM32, an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11). Proc Natl Acad Sci U S A. 2006;103:6287–6292
  23. Loktev AV, Zhang Q, Beck JS, et al. A BBSome subunit links ciliogenesis, microtubule stability, and acetylation. Dev Cell. 2008;15:854–865
  24. Samardzija M, Wenzel A, Naash M, et al. Rpe65 as a modifier gene for inherited retinal degeneration. Eur J Neurosci. 2006;23:1028–1034
  25. Shankar SP, Fingert JH, Carelli V, et al. Evidence for a novel x-linked modifier locus for Leber hereditary optic neuropathy. Ophthalmic Genet. 2008;29:17–24
  26. Stone EM. Finding and interpreting genetic variations that are important to ophthalmologists. Trans Am Ophthalmol Soc. 2003;101:437–484
  27. Philp AR, Jin M, Li S, et al. Predicting the pathogenicity of RPE65 mutations. Hum Mutat. 2009;30:1183–1188
  28. Oh KT, Weleber RG, Stone EM, et al. Electroretinographic findings in patients with Stargardt disease and fundus flavimaculatus. Retina. 2004;24:920–928
  29. Maugeri A, Meire F, Hoyng CB, et al. A novel mutation in the ELOVL4 gene causes autosomal dominant Stargardt-like macular dystrophy. Invest Ophthalmol Vis Sci. 2004;45:4263–4267
  30. Perrault I, Hanein S, Gerber S, et al. Evidence of autosomal dominant Leber congenital amaurosis underlain by a CRX heterozygous null allele. J Med Genet. 2003;40:e90
  31. Plasilova M, Stoilov I, Sarfarazi M, et al. Identification of a single ancestral CYP1B1 mutation in Slovak Gypsies (Roms) affected with primary congenital glaucoma. J Med Genet. 1999;36:290–294
  32. Chen Y, Jiang D, Yu L, et al. CYP1B1 and MYOC mutations in 116 Chinese patients with primary congenital glaucoma. Arch Ophthalmol. 2008;126:1443–1447
  33. Weisschuh N, Wolf C, Wissinger B, Gramer E. A clinical and molecular genetic study of German patients with primary congenital glaucoma. Am J Ophthalmol. 2009;147:744–753
  34. Reiners J, Nagel-Wolfrum K, Jurgens K, et al. Molecular basis of human Usher syndrome. Exp Eye Res. 2006;83:97–119
  35. Cremers FP, Kimberling WJ, Kulm M, et al. Development of a genotyping microarray for Usher syndrome. J Med Genet. 2007;44:153–160
  36. Mullins RF, Oh KT, Heffron E, et al. Late development of vitelliform lesions and flecks in a patient with Best disease: clinicopathologic correlation. Arch Ophthalmol. 2005;123:1588–1594
  37. Blodi C, Stone E. Best's vitelliform dystrophy. Ophthalmic Paediatr Genet. 1990;11:49–59

PII: S0002-9394(09)00664-3

doi: 10.1016/j.ajo.2009.08.038

American Journal of Ophthalmology
Volume 149, Issue 1 , Pages 10-17.e2 , January 2010

Article Tools